Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation

MIAMI (October 25, 2021) – We at Makana Therapeutics and Recombinetics would like to take this opportunity to congratulate our good friend and colleague Dr. Robert Montgomery and his team at N.Y.U. Langone for their recent breakthrough experiment transplanting a Gal-knockout pig kidney into a recently deceased human with an [...]

Makana Statement about Transplant of Gal-Knockout Pig Kidney into a Recently Deceased Human with an Intact Circulation2021-10-27T14:08:12-05:00

Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation

EAGAN, Minn., Sept. 15, 2021 /PRNewswire/ -- Makana Therapeutics today received a $650,000 KidneyX Artificial Kidney Prize for their work to increase the supply of kidney donor organs through pig-to-human xenotransplants. Xenotransplantation is the process of transplanting organs or tissues between members of different species into humans, thus addressing the [...]

Makana Therapeutics Awarded KidneyX Artificial Kidney Prize for Innovation in Xenotransplantation2021-09-21T08:40:23-05:00

First GM pigs for allergies. Could xenotransplants be next?

The FDA greenlights α-Gal allergy-safe meat, but its makers have organs for transplants in their sights. The first genetically engineered pig products could soon be coming to a dinner plate—or pharmacy—near you. Late last year, the US Food and Drug Administration (FDA) authorizeda facility in northern Iowa to raise hogs [...]

First GM pigs for allergies. Could xenotransplants be next?2021-04-19T10:46:00-05:00

Recombinetics Announces Study to Improve Outcomes for Rare Disease Patients

Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a first-of-its-kind study to improve outcomes for patients diagnosed with a rare disease known as Tuberous Sclerosis Complex (TSC). Surrogen, a subsidiary of Recombinetics Inc., is focused on developing large animal models [...]

Recombinetics Announces Study to Improve Outcomes for Rare Disease Patients2020-12-01T09:14:33-06:00

Precision Crossbreeding of African Dairy Production Systems

EAGAN, Minn., Sept. 24, 2020 /PRNewswire/ -- Acceligen, a Recombinetics Inc. company, today announced that it received a grant from the Bill & Melinda Gates Foundation to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. The breeding program will contribute to more sustainable production by using traits [...]

Precision Crossbreeding of African Dairy Production Systems2021-09-21T08:37:48-05:00

Recombinetics Merges with Makana Therapeutics to Accelerate Xenotransplantation

Eagan, MN, October 7, 2020–Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts with Makana Therapeutics, a leader in the field of xenotransplantation. Makana Therapeutics will become Recombinetics Inc.’s newest subsidiary and will be exclusively focused on solving [...]

Recombinetics Merges with Makana Therapeutics to Accelerate Xenotransplantation2020-10-19T11:09:11-05:00
Go to Top